Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study

We investigated the efficacy and safety of dual bronchodilation with QVA149 versus its monocomponents indacaterol and glycopyrronium, tiotropium and placebo in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). This was a multicentre, randomised, double-blind, placebo- an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bateman, Eric D., Ferguson, Gary T., Barnes, Neil, Gallagher, Nicola, Green, Yulia, Henley, Michelle, Banerji, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844137/
https://www.ncbi.nlm.nih.gov/pubmed/23722616
http://dx.doi.org/10.1183/09031936.00200212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844137/
https://www.ncbi.nlm.nih.gov/pubmed/23722616
http://dx.doi.org/10.1183/09031936.00200212

Ejemplares similares